Atlas Trials

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

Clinical trial NCT01578252 · COMPLETED

Trial details

NCT number
NCT01578252
Sponsor
IPCA Laboratories Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting State
Start date
2011-05-01
Primary completion
2011-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.